The association among age, early mitral leaflet closure, cardiac structure, diastolic indices and NT-proBNP in an asymptomatic Taiwanese population  by Chen, Chi et al.
IJC Heart & Vasculature 8 (2015) 114–121
Contents lists available at ScienceDirect
IJC Heart & Vasculature
j ourna l homepage: ht tp : / /www. journa ls .e lsev ie r .com/ i jc -hear t -and-vascu la tureThe association among age, early mitral leaﬂet closure, cardiac structure,
diastolic indices and NT-proBNP in an asymptomatic
Taiwanese populationChi Chen a,1, Yung-Tzi Chen b,1, Kuang-Te Wang b, Shou-Chuan Shih c, Chuan-Chuan Liu d, Jen-Yuan Kuo a,e,
Charles Jia-Yin Hou a,e, Yih-Jer Wu a,e, Chung-Lieh Hung a,e,⁎, Hung-I Yeh a,e,⁎
a Department of Medicine, Mackay Medical College, New Taipei City, Taiwan
b Division of Cardiology, Department of Internal Medicine, Mackay Memorial Hospital, Taitung Branch, Taiwan
c Division of Gastroenterology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei Branch, Taiwan
d The Institute of Health Policy and Management, College of Public Health, National Taiwan University, Taiwan
e Division of Cardiology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei Branch, Taiwan⁎ Corresponding authors at: Cardiovascular Division, D
Mackay Memorial Hospital, No. 92, Chung-Shan Nort
Memorial Hospital, Taipei 100, Taiwan.
E-mail addresses: jotaro3791@gmail.com (C.-L. Hung)
(H.-I. Yeh).
1 Both authors contributed equally to this work.
http://dx.doi.org/10.1016/j.ijcha.2015.06.007
2352-9067/© 2015 Published by Elsevier Ireland Ltd. Thisa b s t r a c ta r t i c l e i n f oArticle history:
Received 26 January 2015
Received in revised form 17 June 2015
Accepted 19 June 2015








Background: Advanced age is associated with left ventricular (LV) remodeling and impaired diastole. The associ-
ation among aging, mitral leaﬂet closure (EF slope), cardiac structures, and diastolic indices in an asymptomatic
Taiwanese population is largely unknown.
Methods:We studied 8103 asymptomatic participants (49.5 ± 11.6 years, 38.2% women) from a health evalua-
tion cohort (2004–2012) in a tertiary center in Taiwan. Echo-derived LV structure/function, and M-mode based
EF slope (mm/s) and serumNT-proBNP levelwere obtained. The association between EF slope and the other clin-
ical or echo-based parameters was investigated.
Results: Average values for EF slope among various age groups in the Taiwanese population were determined for
both genders. Advanced age was associated with reductions in EF slope (adjusted estimate:−0.35/per decade).
Reduced EF slope was associated with older age, higher blood pressure and greater body mass index in multi-
variate models (all p b 0.05). Reduced EF slope was correlated with greater cardiac concentricity, abnormal E′
and E/E′ (AUROC: 0.74 and 0.77, respectively, both p b 0.05) and elevated NT-proBNP (Coef: 5.98 pg/mL, per
−10 mm/s EF slope, 95% CI: 7.82 to 4.17, p b 0.001). EF-slope also clearly discriminated individuals with abnor-
mal estimated LV ﬁlling (E/E′ categorized by b8, ≥8 & b15, ≥15, ANOVA p b 0.001).
Conclusions: EF-slope reduction in the asymptomatic Taiwanese population was correlated with age, several
unfavorable LV remodeling, and impaired diastolic function parameters, and EF-slope can be an effective clinical
diagnostic tool for identifying poor E′ and elevated LV ﬁlling pressure. In addition, our data provided reference
values for EF-slope in various age groups.
© 2015 Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Increasing age has long been shown to be associated with a higher
incidence of cardiovascular disease. [1] Cardiac remodeling with aging,
an adaptation tightly linked to clinical heart failure, had been reported
to be produced by numerous physiological and pathological mecha-
nisms [2,3]. Currently, echocardiographic measurement of M-modeepartment of Internal Medicine,
h Road, 2nd Section, Mackay
, yehmmc@mmc.edu.tw
is an open access article under the Cbased and 2-dimensional (2D)-deﬁned left ventricular (LV) systolic
function, especially left ventricular ejection fraction (LVEF), is load
dependent, and these measurements are regarded as having low sensi-
tivity to the earlier stages of myocardial dysfunction [4,5]. Instead, the
cardiac remodeling process with aging can be detected by worsened
functional presentation in several parameters, for example, diastolic
dysfunction.
Of the several diastolic indices that have been investigated for use in
the past decades, the EF slope measurement from conventional M-
mode echocardiography, a measurement reﬂecting the rate of early
diastolicmitral leaﬂet closing [6], has long been proposed as ameasure-
ment for diastolic function [7]. As a variety of new diastolic parameters
including Tissue Doppler Imaging (TDI) have been proposed in recent
years, the clinical utilization of EF slope has been largely replaced byC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ever, the clinical use of these parameters, especially the Doppler-based
techniques, is highly dependent on technique, may heavily rely on the
operator's experience, and produces limited information on regional
rather than global cardiac function [9,10].
There are few current data scarce regarding how EF slope correlates
with age-related cardiac remodeling or related elevated load status in
the Taiwanese population. In addition, sex differences in such associa-
tions remain relatively unexplored. Understanding this information
may provide insight as to how EF slope measurement may be clinically
useful when performed in daily practice. Based on these considerations,
we aimed to investigate the relationship between EF slope and cardiac




This study utilized the dataset from subjects who underwent a
cardiovascular survey fromMackay Memorial Hospital, a tertiary med-
ical center at Northern Taipei, that was conducted during the period
from July 2003 to December 2012. A total of 11,376 persons underwent
anthropometric measurements, body fat composition assessment,
comprehensive echocardiography studies and 12-lead resting electro-
cardiography and had blood drawn for biochemical information and cir-
culating biomarkers. Structured questionnaires were obtained from all
participants. Of the total number of subjects, 9058 had baseline visits
that included non-repeated echocardiography data. We excluded sub-
jects with missing baseline variables, known implanted pacemaker, se-
vere pulmonary hypertension (deﬁned as peak systolic pulmonary
artery pressure ≥ 60 mm Hg), hypertrophic cardiomyopathy, atrial ﬁ-
brillation, primary signiﬁcant valvular heart disease (aortic or mitral
valve), or prevalent symptoms of heart failure (n= 1045). Some partic-
ipants underwent repeated visits, and for these patients, we used infor-
mation from the ﬁrst visit as data for this study.
2.2. Echocardiography
All study subjects undergoing transthoracic echocardiography
were positioned in the left decubitus position after an adequateFig. 1. Illustration of individual landmarks (A, C, D, E and F points) of a transthoracic parasternal
(right panel).resting time. A Philips (Hewlett-Packard) Sonos 5500 ultrasound
was initially used for conventional echocardiography scans, with
M-mode, two-dimensional (2D) and hemodynamic Doppler images
acquired per standardized protocol using a 2–4-MHz adult cardiac
transducer (S4, phased array transducer). Pulsed wave TDI was
available after July 2007, and enabled myocardial and mitral annular
sampling (1.5 mm) and contraction/relaxation velocity (S′/E′, unit in
cm/s) to be available and feasible with the highest frame rate to be
performed, thus facilitating diastolic function grading. After January
2009, echocardiography was uniformly performed using a GE system
(Vividi, Vingmed, Horten, Norway) equipped with the 2–4-MHz
transducer. For both systems, the standard echocardiography imag-
ing protocol included M-mode based measurement of LA diameter,
LV end-diastolic/-systolic diameter (LVIDd and LVIDs), wall thick-
ness, and LV mass calculation (American Society of Echocardiogra-
phy criteria) [11] with LV volumes obtained by the modiﬁed
biplane Simpson method by 2D. All M-mode images were acquired
and recorded at a speed of 60–100 mm/s with the transducer placed
at the third to the ﬁfth inter-costal space.
For EF slope measure, recordings were made using leading-edge
methods according to the standards suggested by the American So-
ciety of Echocardiography [12]. The manual tracing of anterior mi-
tral leaﬂet closure after rapid early ﬁlling was displayed byM-mode
imaging, and was determined by drawing a line from the E to the F
point (Fig. 1) by a single experienced technician. A steeper EF slope
(unit: mm/s) represented rapid and normal ﬁlling of LV during the
early diastolic phase while a more damped and slowed slope pat-
tern was observed in subjects with impaired LV diastolic function
[13]. The intra- and inter-observer variability (coefﬁcient of vari-
ance) for LV wall thickness, diastolic diameter and M-mode based
EF slope measurement from a random set of 30 subjects in our lab-
oratory was 7.2%, 6.1% and 5.8% and 7.4%, 6.8% and 6.2%,
respectively.
LV hemodynamic diastolic assessment was determined by using
pulsed-wave transmitral inﬂow Doppler imaging of early (E) and late
diastolic (A) LVﬁlling velocitiesmeasured at the tip of themitral leaﬂets
from an apical 4-chamber view, with high frame rates. LV ﬁlling pres-
sure was estimated by themitral E/E′ ratio. Impaired mitral annulus di-
astolic relaxation velocities (E′ b 8 cm/s, E′ asmean for both medial and
lateral mitral annular sampling) was used to make the diagnosis of dia-
stolic dysfunction [14], with anE/E′ (same averaged E′ frombothmediallong-axisM-mode tracing (left panel) and a representative EF slope from amanual tracing
Table 1
Baseline characteristics of study participants.
Women (N = 3060) Men (N = 4953) p value
Baseline characteristics
Age, y 51.1 ± 12.0 49.5 ± 11.3 b0.0001
Height, cm 157 ± 5.7 170 ± 6.2 b0.0001
Weight, kg 56.8 ± 9.3 72.0 ± 11.1 b0.0001
Body mass index 23.2 ± 3.7 25.0 ± 3.4 b0.0001
SBP, mm Hg 120 ± 19.1 124.8 ± 16.3 b0.0001
DBP, mm Hg 72.5 ± 10.6 77.7 ± 10.6 b0.0001
MBP, mm Hg 88.4 ± 12.5 93.4 ± 11.6 b0.0001
Heart rate, 1/min 74.1 ± 9.6 74.3 ± 10.6 0.5222
Waist circumference, cm 77.0 ± 9.8 86.4 ± 8.9 b0.0001
Biochemical data
Fasting glucose, mg/dL 98.3 ± 23.8 102.7 ± 24.6 b0.0001
Cholesterol, mg/dL 200.7 ± 38 198.9 ± 36 0.0375
HDL, mg/dL 62 ± 15.7 48.8 ± 12.1 b0.0001
eGFR, mg/dL 92.6 ± 20.1 85.7 ± 15.7 b0.0001
Medical history, %
Hypertension 586 (19.2%) 956 (19.3%) 0.891
Hyperlipidemia 75 (2.5%) 125 (2.5%) 0.897
Diabetes mellitus 206 (6.7%) 322 (6.5%) 0.72
Cardiovascular disease 282 (9.2%) 369 (7.5%) 0.006
DBP: diastolic blood pressure, eGFR: estimated glomerular ﬁltration rate, HDL: high densi-
ty lipoprotein, MBP: mean blood pressure and SBP: systolic blood pressure.
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the diagnostic criteria for an elevated end-diastolic pressure or ﬁlling,
as previously described [8,9].
2.3. Serum NT-proBNP test and renal functional assessment
NT-proBNP (pg/mL) was available for 5207 study participants (65%)
using an electrochemiluminescence immunoassay (Roche E170, Roche
Diagnostics). Major baseline demographic information including
age, sex distribution, body size, blood pressure and medical history
did not differ signiﬁcantly between study participants with or without
NT-proBNP data. Renal function was assessed using the Modiﬁcation
of Diet in Renal Disease (MDRD) formula.
2.4. Statistical analysis
Continuous data were shown as mean and standard deviation and
compared using the t test. Categorical datawere expressed as frequency
and proportion of occurrence in all subjects and were compared using
the chi-square test. The associations among EF slope, age, NT-proBNP
and various cardiac structural/functional indices were analyzed usingTable 2
Reference value for EF slope in all study participants (n = 8013) and healthy participants in th
Age groups All (n = 8013) Men Women
≤30 (years) Mean ± SD 111 ± 26.6 101 ± 23.9
N 247 133
31–40 (years) Mean ± SD 103.7 ± 25.6 99.5 ± 23.9
N 984 436
41–50 (years) Mean ± SD 96.1 ± 25.9 93.2 ± 23.5
N 1677 892
51–60 (years) Mean ± SD 85.1 ± 27.1 83.2 ± 22.8
N 1377 948
61–70 (years) Mean ± SD 73.7 ± 25.8 71.3 ± 25.1
N 478 469
≥71 (years) Mean ± SD 64.8 ± 23 59 ± 22.4
N 190 182
p for trend (across age groups) b0.001 b0.001
All subjects Mean ± SD 91.9 ± 28.4 86 ± 26.1
N 4953 3060
SD: standard deviation.univariate regression models. We also used a multivariate model to
determine the signiﬁcance of the relationship between EF slope and
age adjustedwith clinical covariates such as fasting glucose, cholesterol,
HDL, eGFR, andmedical history of hypertension, diabetes, and hyperlip-
idemia. Receiving operative characteristic (ROC) curves were used to
test the hypothesis that EF slope provides value in the detection of
abnormal diastolic dysfunction, including impaired myocardial relaxa-
tion and impaired LV ﬁlling capacity. p value was set at two-tailed
probability, and a p value less than 0.05 was considered statistically
signiﬁcant. Software packages IBM SPSS version 22.0 (SPSS, Chicago,
IL, USA) and STATA 8.2 (StataCorp, College Station, TX, USA) were
used to conduct the statistical analyses.
3. Results
3.1. Baseline characteristics
In Table 1, we show the baseline characteristics of the study partici-
pants (n = 8013) by genders. In general, females were older, and had
lower body length and body weight, smaller waist circumference, and
smaller body size (all p b 0.001). Men showed greater blood pressure
proﬁles (all p b 0.001) and had a higher fasting glucose level, lower
HDL and lower eGFR compared to women (all p b 0.001).
3.2. Age-related EF slope reduction and its correlation to other clinical
variables
Table 2 shows age-related changes in EF slope stratiﬁed by gender for
all participants (n= 8013) (Table 2, Fig. 2A), and for those in the healthy
population (n=5839)without histories of hypertension, diabetes, use of
medication for hyperlipidemia, and known cardiovascular diseases. The
mean EF slope in all study participants and in the healthy population
was 89.7 ± 27.7 and 93.6 ± 26.8 mm/s, respectively. Both populations
showed a similar and signiﬁcant trend toward a more reduced EF slope
with older age groups (both trends p b 0.001), with a nearly 30–40% re-
duction from the b30 to the N70 year age group in men and women. In
general, men showed a greater EF slope compared to women.
Table 3 also shows the association between age and reduction of EF
slope in univariate and multivariate models. For all study participants
(n = 8013, Table 3A) and healthy group participants (n = 5839,
Table 3B), an increase in age (per decade) is associatedwith a signiﬁcant
decline in the EF slope for both genders even after adjustment for
clinical covariates (Fig. 2A). In addition, higher blood pressure and
greater body size are both independently related to EF slope reduction
(all p b 0.05) in multivariate models from both genders.e current study (n = 5839).
p value Healthy (n = 5893) Men Women p value
b0.001 Mean ± SD 111 ± 27 100.5 ± 24.4 b0.001
N 223 120
0.004 Mean ± SD 104.9 ± 25 99.5 ± 23.6 0.003
N 867 394
0.006 Mean ± SD 97.4 ± 25.9 93.2 ± 23.4 0.02
N 1320 757
0.0771 Mean ± SD 87.2 ± 27.2 83.2 ± 22.3 0.203
N 904 650
0.155 Mean ± SD 75.6 ± 24.9 71.3 ± 24.9 0.895
N 231 235
0.0147 Mean ± SD 71 ± 24 59 ± 20.2 0.003
N 73 65
b0.001 b0.001
Mean ± SD 95.6 ± 27.7 90.3 ± 25 b0.001
n 3618 2221
Fig. 2. Association between age, EF slope, and several cardiac structural parameters. Unfavorable cardiac remodeling, including greater wall thickness and larger mass, are all associated
with reduced EF slope, with men demonstrating a positive linear trend between higher EF slope and greater LV internal diameter.
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measures
Table 4 and Fig. 2B–I show the relationship between EF slope and
several cardiac structure and functional indices in all participants
(n= 8013) and in healthy participants without hypertension, diabetes,
hyperlipidemia and prior cardiovascular diseases (n = 5893). For all
study participants, greater LVwall thickness (both IVS and LVPW) is as-
sociated with lower EF slope (r = −0.17 & −0.14, both p b 0.001,
Table 4, Fig. 2E and F). In contrast, greater LV internal chamber diameter
is associated with greater EF slope (all p b 0.001, Table 4, Fig. 2G and H).
A modest inverse relationship was observed between EF slope and
fractional shortening (r = −0.05, p b 0.001, Fig. 2I), with greater LV
mass (with or without index, Fig. 2C and D) related to more reduced
EF slope (r =−0.11 & -0.04, respectively, both p b 0.001). The associa-
tion between EF slope and LV internal diameter (both systolic and dia-
stolic) is more pronounced in men than that in women (p for
interaction: b0.05). Similar results are shown for healthy participants.
Finally, the relationships between various cardiac structural quintiles
and EF slope measurement from all study participants (n = 8013) are
shown in Supplemental Fig. 1.3.4. Association between EF slope, diastolic indices, and NT-proBNP
Table 4 shows the association between EF slope and clinically
deﬁned impaired diastolic indices. An inverse association between
lower EF slope value and greater LA size (Table 4, Fig. 2B) and more
prolonged DT/IVRT is observed, with higher E, lower A and higher E/A
related to greater EF slope (all p b 0.001). Higher mitral annular relaxa-
tion velocity E′ and lower E/E′ are both associated with higher EF
slope (both p b 0.001), with lower EF slope related to higher serum
NT-proBNP levels (r=−0.17, p b 0.001) (Fig. 3, left panel). A signiﬁcant
graded reduction in EF slope was observed over categorized E/E′
(98.9 ± 26.6 vs 82.8 ± 26 vs 63.2 ± 26.2 mm/s for E/E′ categorized as
b8, 8–15, ≥15, respectively) (Fig. 3, right panel, ANOVA p b 0.001).
Lower EF slope is associated with increased risk of having diastol-
ic dysfunction in terms of impaired myocardial relaxation (deﬁned by
E′ b 8 cm/s) (OR: 2.64, 95% conﬁdence interval: 2.43–2.87, p b 0.001)
or impaired LV ﬁlling capacity or compliance (deﬁned by E/E′ ≥ 15)
(OR: 3.01, 95% conﬁdence interval: 2.24–4.05, p b 0.001). For every
10 mm/s reduction in EF slope, there was a signiﬁcantly higher
NT-proBNP concentration (Coef: 5.98 pg/mL, per −10 mm/s EF
slope, 95% CI: 7.82 to 4.17, p b 0.001). The area under the ROC
Table 3
Association between age, load status and EF slope measurement in uni- and multi-variate models for all (n = 8013) and healthy participants (n = 5893).
EF slope (mm/s)
Female (n = 3060) Male (n = 4953) All study participants (n = 8013)
Beta p Beta p Beta p
Univariate
Age (per decade) −9.63 b0.001 −10.19 b0.001 −10.11 b0.001
Multivariate
Model 1
Age (per decade) −8.19 b0.001 −9.54 b0.001 −9.32 b0.001
SBP (per 10 mm Hg) −1.91 b0.001 −2.04 b0.001 −1.69 b0.001
Model 2
Age (per decade) −8.03 b0.001 −9.68 b0.001 −9.37 b0.001
SBP (per 10 mm Hg) −1.6 b0.001 −1.71 b0.001 −1.42 b0.001
BMI (per 5 kg/m2) −2.56 b0.001 −3.25 b0.001 −2.01 b0.001
Model 3a
Age (per decade) −7.51 b0.001 −8.95 b0.001 −8.9 b0.001
SBP (per 10 mm Hg) −0.98 0.001 −1.45 b0.001 −1.04 b0.001
BMI (per 5 kg/m2) −1.45 0.036 −2.36 b0.001 −1.57 0.001
Female (n = 2221) Male (n = 3618) Healthy participants (n = 5893)
Beta p Beta p Beta p
Univariate
Age (per decade) −8.4 b0.001 −9.47 b0.001 −9.17 b0.001
Female (n = 3060) Male (n = 4953) Healthy participants (n = 5893)
Beta p Beta p Beta p
Multivariate
Model 1
Age (per decade) −7.66 b0.001 −9.13 b0.001 −8.82 b0.001
SBP (per 10 mm Hg) −1.33 b0.001 −1.59 b0.001 −1.1 b0.001
Model 2
Age (per decade) −7.39 b0.001 −9.26 b0.001 −8.86 b0.001
SBP (per 10 mm Hg) −0.9 0.009 −1.28 b0.001 −0.81 b0.001
BMI (per 5 kg/m2) −3.65 b0.001 −2.89 b0.001 −2.08 b0.001
Model 3b
Age (per decade) −6.99 b0.001 −8.68 b0.001 −8.65 b0.001
SBP (per 10 mm Hg) −0.89 0.016 −1.46 b0.001 −0.91 b0.001
BMI (per 5 kg/m2) −2.94 0.001 −2.28 0.002 −2.03 b0.001
Beta: beta co-efﬁciency, BMI: body mass index, SBP: systolic blood pressure.
a Model 3: CV indicates clinical variables including fasting glucose, cholesterol, HDL, eGFR, medical history of hypertension, diabetes, CVD, and hyperlipidemia.
b Model 3: CV indicates clinical variables including fasting glucose, cholesterol, HDL, and eGFR.
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0.75) and 0.77 (95% conﬁdence interval: 0.72–0.83) for identifying
signiﬁcantly worsened E′ (b8 cm/s) and abnormally high E/E′
(Fig. 4).Table 4
Association between EF slope and various cardiac structural/functional indices.
(Per 1 SU increase) All study participants (n = 8013)
Beta S.E. p value
IVS −0.17 0.29 b0.001
LVPW −0.14 0.29 b0.001
LVIDd 0.14 0.09 b0.001
LVIDs 0.11 0.1 b0.001
FS −0.05 0.08 b0.001
LV mass −0.04 0.01 b0.001
LV mass index −0.11 0.02 b0.001
LA diameter −0.12 0.07 b0.001
DT −0.29 0.01 b0.001
IVRT −0.2 0.03 b0.001
E 0.12 0.03 b0.001
A −0.42 0.02 b0.001
E/A 0.41 0.9 b0.001
TDI E′ 0.46 0.15 b0.001
E/E′ −0.32 0.16 b0.001
A: latemitral inﬂow velocity, DT:mitral inﬂowdeceleration time, E: earlymitral inﬂowvelocity
E′ ratio, FS: fractional shortening, IVRT: iso-volumic relaxation time, IVS: inter-ventricular septa
systolic left ventricular internal diameter, LVPW: left ventricular posterior wall, SU: standardiz4. Discussion
In our current work, we demonstrated that advanced age is asso-
ciated with worsening EF slope in a large asymptomatic population,(Per 1 SU increase) Healthy participants (n = 5893)
Beta S.E. p value
IVS −0.11 0.34 0.29
LVPW −0.08 0.35 0.29
LVIDd 0.18 0.1 0.09
LVIDs 0.16 0.11 0.1
FS −0.07 0.1 0.08
LV mass 0.02 0.01 0.111
LV mass index −0.03 0.03 0.011
LA diameter −0.05 0.08 0.001
DT −0.15 0.01 b0.001
IVRT −0.16 0.03 b0.001
E 0.11 0.03 b0.001
A −0.37 0.02 b0.001
E/A 0.36 1.05 b0.001
TDI E′ 0.4 0.17 b0.001
E/E′ −0.25 0.22 b0.001
, E/A:mitral inﬂowE/A ratio, E/E: earlymitral inﬂowE tomitral annulus relaxation velocity
l wall thickness, LA: left atrial/atrium, LV: left ventricular/ventricle, LVIDd/LVIDs: diastolic/
ed unit and TDI E′: mitral annulus relaxation velocity E′.
Fig. 3. Linear correlation between EF slope andNT-proBNP level (left panel). Signiﬁcant graded reduction of EF slope based on categorized LVﬁlling pressuredeﬁned by E/E′ (98.9±26.6 vs
82.8 ± 26 vs 63.2 ± 26.2 mm/s, respectively).
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including greater LV wall thickness (both IVS and LVPW), and greater
LV mass. In addition, we further observed that lower EF slope may par-
allel several diastolic functional changes and elevated NT-proBNP level.
These features, when taken together, have long been regarded as clini-
cal hallmarks of cardiac aging. The clinical signiﬁcance of our current
work can be two-folds. Firstly, EF slope measure is tightly associated
with unfavorable geometries together with aging, with lower EF slope
reﬂecting greater cardiac concentricity. The second,we show in our cur-
rent data that daily conventional echocardiography measures based on
M-mode EF slope, except for the Doppler-based method, is capable of
providing a clinical alternative marker for identifying subjects present
with key features of diastolic dysfunction. To this end, we further pro-
vided the reference ranges based on sex and various age groups in rel-
ative large Taiwanese population.
4.1. The association between advanced age and EF slope reduction
With aging, both the arterial system and the ventricles may undergo
a degree of remodeling, or stiffening, due to a number of biological/
pathological changes that lead to excessive extracellular or interstitial
deposition of matrix proteins and collagen ﬁbers, impaired cardiac
diastolic ﬁlling, worsened compliance and functional uncoupling
[15–18]. At the same time, changes in contractile mechanics, such
as LV twist and torsion, may occur that compensate for age-related
functional loss at early stages to preserve global LV systolic functionFig. 4. Panels A and B show AUROC for predicting abnormally low E′ (b8 cm/s) and high E/E′ (N
and 79.5 cm/s2, with sensitivity/speciﬁcity 70%/67.9% and 72.2%/70.8%, respectively.in terms of ejection fraction [19,20]. Measures capable of evaluating
distensibility or the ability of the ventricle to relax may be able to de-
tect cardiac change at earlier times than detection of systolic func-
tional decline or clinical heart failure [21].
EF slope represents mechanical motion in response to early dia-
stolic closure of the anterior mitral leaﬂet [22], and reﬂects the me-
chanical motion that is driven by decelerating transmitral inﬂow
hemodynamics of the global LV [6,23]. Therefore, factors related
to diminished ventricular diastolic compliance, such as cardiac
remodeling in relation to the aging process or even mildly elevated
blood pressure [24], may lead to a decrease in transmitral ﬂow and
a lower EF slope value. Although previous research has indicated
better sensitivity for early diastolic ﬁlling as a structural/functional
indicator of LV function, our current ﬁndings on detecting abnor-
mal key diastolic surrogates (deﬁned as abnormal E′ or E/E′) by
EF slope based on M-mode show that this method could be an
important clinical alternative measure to supplement the current
Doppler-based diastolic parameters used for this purpose [25].
4.2. Association between reduced EF slope and impaired conventional
diastolic indices
More recently, data from several non-invasive, echocardiographic
measures have shown that simultaneous and combined evaluation of
transmitral ﬂow velocity (hydrostatic driving force) and annular veloc-
ity (activemyocardial relaxation), such as E/E′ ratio by TDI, may bemost15) by EF slope. The cut-off values for EF slope in identifying abnormal E′ and E/E′ are 87.5
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sive catheterization [8,9]. Though EF slope as a measure or LV diastolic
function has been proposed to behighly correspondent to early diastolic
mitral inﬂow deceleration velocity and been shown to be a function of
the amount and velocity of blood passing through the mitral leaﬂet
[26,27], its speciﬁcity and the exact correlation between these two
measures based on larger sample sizes has not been thoroughly ex-
plored. Nevertheless, factors postulated to be associated with the de-
crease of EF slope by M-mode in the context of elevated LV stiffness,
altered afterload status or worsened LV compliance may also explain
the more prolonged early diastolic mitral inﬂow deceleration time
(DT) [15,28], as observed in our data.
4.3. The association between reduced EF slope and impaired myocardial
relaxation and ﬁlling
While it has been proposed in recent years that diastolic ﬁlling
energy may start from the isovolumic phase and facilitate
ventricular suction, mechanistic insight into the understanding of
diastolic rheology is still a challenge, despite the more novel echo-
based techniques that are still evolving [6,14,29,30]. Interestingly, we
observed a good correlation between myocardial/mitral annulus
relaxation velocity E′, and also a good prediction ability of reduced EF
slope in identifying worse E′ and elevated LV ﬁlling pressure (AUROC:
0.74 & 0.77, respectively, both p b 0.001). The most likely cause for
such ﬁndings may be that myocardial relaxation velocity could be
themajor mechanical driving force for rapid early mitral ﬁlling, causing
a faster and synergistic suction ﬂow toward the LV and a steeper
descent of the EF slope [8,9]. These associations were further con-
ﬁrmed by the inverse relationship observed between EF slope
and serum NT-proBNP level, an observation that further strengthened
our hypothetical link between impeded diastolic ﬁlling as the main
reason for worsened mitral leaﬂet closure because NT-proBNP is an
effective indicator of heart diastolic function [31]. Though we
acknowledge that our current work may be limited by the lack of a
causal-relationship between older age or more elevated afterload on
the effect of reduction in the M-mode based EF slope measure-
ment, we have shown in our data that in such evaluation, a conven-
tional measurement with high availability in daily practice, may
be clinically feasible and useful in identifying subjects with suspected
impaired diastolic function. Therefore, we propose EF slope to be a
clinical alternativemarker for diastolic functional assessment in asymp-
tomatic subjects. In addition, whether such data may be extended to a
population presenting with clinical heart failure as a continuum of
more advanced diastolic dysfunction of myocardial asynergy, will
need further investigation. To our best knowledge, this is the ﬁrst
work comparing and exploring the correlations between mitral leaﬂet
EF slope and various new diastolic parameters with a relatively large
sample size in an asymptomatic population.
5. Conclusions
Though clinical practice and the body of knowledge on diastolic
function continues to evolve, we have shown in our work that EF slope
measurement byM-mode echocardiography, a potential marker relevant
to the rate of earlymitral leaﬂet closure, is tightly associatedwith age and
load status. Further, this simple measurement may be related to several
advanced diastolic indices and have the highest correlation with mitral
annulus relaxation velocity, and be regarded as themost sensitive diastol-
ic parameter in daily use. The limitation of this study is that it is a single
center study. Therefore, it may not represent general community data,
and studies in different populations are needed. However, we have also
provided a normal reference range for EF slopemeasurement in different
age groups for the Taiwanese population that may serve as a useful guide
in evaluating subjects with suspected diastolic dysfunctionwithout other
feasible markers in clinical practice.Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ijcha.2015.06.007.
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